EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Surrogate Immunohistochemical Markers of Proliferation and Embryonic Stem Cells in Distinguishing Ameloblastoma from Ameloblastic Carcinoma

Liam Robinson, Chané Smit, Marlene B van Heerden, Haroon Moolla, Amir H Afrogheh, Johan F Opperman, Melvin A Ambele, Willie F P van Heerden

Head and Neck Pathology · 2024

DOI: 10.1007/s12105-024-01704-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head and Neck Pathology, 2024. Verfasst von Liam Robinson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Pathology, Faculty of Health Sciences, University of Pretoria, Pretoria Oral Health Care Centre, Office 6-11, Co…. Hauptthemen laut MEDLINE: Ameloblastoma, Biomarkers, Tumor, Immunohistochemistry, Cell Proliferation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Development Programme (RDP) grant, University of Pretoria, University of Pretoria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The current study aimed to investigate the use of surrogate immunohistochemical (IHC) markers of proliferation and stem cells to distinguish ameloblastoma (AB) from ameloblastic carcinoma (AC).

Methods

The study assessed a total of 29 ACs, 6 ABs that transformed into ACs, and a control cohort of 20 ABs. The demographics and clinicopathologic details of the included cases of AC were recorded. The Ki-67 proliferation index was scored through automated methods with the QuPath open-source software platform. For SOX2, OCT4 and Glypican-3 IHC, each case was scored using a proportion of positivity score combined with an intensity score to produce a total score.

Results

All cases of AC showed a relatively high median proliferation index of 41.7%, with statistically significant higher scores compared to ABs. ABs that transformed into ACs had similar median proliferation scores to the control cohort of ABs. Most cases of AC showed some degree of SOX2 expression, with 58.6% showing high expression. OCT4 expression was not seen in any case of AC. GPC-3 expression in ACs was limited, with high expression in 17.2% of ACs. Primary ACs showed higher median proliferation scores and degrees of SOX2 and GPC-3 expression than secondary cases. Regarding SOX2, OCT4 and GPC-3 IHC expression, no statistically significant differences existed between the cohort of ABs and ACs.

Conclusion

Ki-67 IHC as a proliferation marker, particularly when assessed via automated methods, was helpful in distinguishing AC from AB cases. In contrast to other studies, surrogate IHC markers of embryonic stem cells, SOX2, OCT4 and GPC-3, were unreliable in distinguishing the two entities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmeloblastomaBiomarkers, TumorImmunohistochemistryCell ProliferationHumansFemaleMaleDiagnosis, DifferentialAdultMiddle AgedEmbryonic Stem CellsJaw NeoplasmsAdolescentYoung AdultOctamer Transcription Factor-3AgedSOXB1 Transcription FactorsChildGlypicans

Stichwörter der Autor:innen

Ameloblastic carcinomaAmeloblastomaImmunohistochemistryOdontogenic neoplasmsProliferation indicesStem cells

Substanzen

Biomarkers, TumorPOU5F1 protein, humanOctamer Transcription Factor-3SOX2 protein, humanSOXB1 Transcription FactorsGPC3 protein, humanGlypicans

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Pathology, Faculty of Health Sciences, University of Pretoria, Pretoria Oral Health Care Centre, Office 6-11, Corner of Steve Biko and Dr Savage Roads, Pretoria, 0084, South Africa.…
  • Department of Oral and Maxillofacial Pathology, Faculty of Health Sciences, University of Pretoria, Pretoria Oral Health Care Centre, Office 6-11, Corner of Steve Biko and Dr Savage Roads, Pretoria, 0084, South Africa.
  • Centre for Infectious Disease Epidemiology and Research, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, University of the Western Cape, Cape Town, South Africa.
  • Division of Anatomical Pathology, Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Institute for Cellular and Molecular Medicine, Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, South African Medical Research Council, University of Pretoria, Pretoria, South Africa.

Förderung

  • Research Development Programme (RDP) grant, University of Pretoria
  • University of Pretoria

Zitieren

APA

Robinson, L., Smit, C., van Heerden, M. B., Moolla, H., Afrogheh, A. H., Opperman, J. F., Ambele, M. A., & van Heerden, W. F. P. (2024). Surrogate Immunohistochemical Markers of Proliferation and Embryonic Stem Cells in Distinguishing Ameloblastoma from Ameloblastic Carcinoma. Head and Neck Pathology. https://doi.org/10.1007/s12105-024-01704-8

Vancouver

Robinson L, Smit C, van Heerden MB, Moolla H, Afrogheh AH, Opperman JF, et al. Surrogate Immunohistochemical Markers of Proliferation and Embryonic Stem Cells in Distinguishing Ameloblastoma from Ameloblastic Carcinoma. Head and Neck Pathology. 2024. doi:10.1007/s12105-024-01704-8

BibTeX
@article{Robinson2024,
  author = {Robinson, Liam and Smit, Chané and van Heerden, Marlene B and Moolla, Haroon and Afrogheh, Amir H and Opperman, Johan F and Ambele, Melvin A and van Heerden, Willie F P},
  title = {Surrogate Immunohistochemical Markers of Proliferation and Embryonic Stem Cells in Distinguishing Ameloblastoma from Ameloblastic Carcinoma},
  journal = {Head and Neck Pathology},
  year = {2024},
  doi = {10.1007/s12105-024-01704-8}
}
Kostenlos starten →